Anzibel (chlorhexidine hydrochloride) lozenges №30 IUd

active ingredients: chlorhexidine hydrochloride, benzocaine, enoxolone;

1 lozenge contains chlorhexidine hydrochloride 5 mg benzocaine 4 mg, enoxolone 3 mg

Excipients:

lozenges: sorbitol (E 420), acesulfame potassium, magnesium stearate

menthol flavored lozenges: sorbitol (E 420), acesulfame potassium, magnesium stearate, menthol flavor

lozenges with honey and lemon flavor: sorbitol (E 420), acesulfame potassium, magnesium stearate, lemon flavor, honey flavor.

Pastilles.

Basic physical and chemical properties: round biconvex pastilles of white or almost white color, smooth on one side and with the “ŋ” logo on the other;

round, biconvex lozenges of white or almost white color, with a menthol smell, smooth on one side and with the “ŋ” logo on the other;

round, biconvex, white or almost white pastilles with a lemon and honey scent, smooth on one side and with the “ŋ” logo on the other.

Drugs used in diseases of the throat. Antiseptics. ATX code R02A A20.

Anzibel (chlorhexidine hydrochloride) is a combined antiseptic preparation for topical use in the oropharyngeal area. The pharmacological effect is provided by the components that make up the drug.

Chlorhexidine is bacteriostatic at low concentrations and bactericidal at high concentrations. The mechanism of action of chlorhexidine is the formation of bonds with the bacterial cell membrane, which leads to a violation of their structure. Active against staphylococci, streptococci, Candida albicans, Escherichia coli and some aerobic and anaerobic bacteria. Weakly sensitive to chlorhexidine Proteus, Pseudomonas, Klebsiella spp.

Benzocaine has a local anesthetic effect in the presence of severe pain. It is used to treat the morning of the oral mucosa or tongue.

Enoxolone has anti-inflammatory and analgesic properties, as well as a pronounced antiviral effect against viruses containing DNA or RNA, as well as various strains of Herpes simplex and Herpes zoster viruses.

Local treatment of symptoms in infectious inflammatory diseases of the oral cavity and pharynx.

Hypersensitivity to the components of Anzibel (chlorhexidine hydrochloride) or known hypersensitivity to other drugs with anesthetic activity, to derivatives of esters with anesthetic activity. Phenylketonuria.